603456: Zhejiang Jiuzhou Pharmaceutical Co., Ltd - Summary | Jitta

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

CHN:603456

Price
CN¥13.79
Loss Chance
41.8%
6.71JITTA SCORE
40.82%Under Jitta Line
Jitta Ranking
262 / 487
2,490 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (71)
Recent Business Performance (96)
Financial Strength (95)
Return to Shareholders (43)
Competitive Advantage (63)
Jitta Signs
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Revenue and EarningRevenue decline from 2022-2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 34.30% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.71
40.82%
4.42
> 1,000%
4.24
> 1,000%
Pharmaceuticals
6.36
2.64%
5.47
25.22%
7.76
43.10%
COMPANY DESCRIPTION
Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.